Patient's Perception of Treatment Outcome With Darifenacin by Patients With Overactive Bladder

PHASE4CompletedINTERVENTIONAL
Enrollment

500

Participants

Timeline

Start Date

June 30, 2006

Study Completion Date

September 30, 2007

Conditions
Overactive Bladder (OAB)
Interventions
DRUG

Darifenacin

Darifenacin 7,5 mg tablets once daily with the possibility to up-titrate to 15 mg once daily

Trial Locations (82)

11501

Investigative Site, Mineola

11530

Investigative Site, Garden City

12110

Investigative Site, Latham

12180

Investigative Site, Troy

12206

Investigative Site, Albany

12601

Investigative Site, Poughkeepsie

13413

Investigative Site, New Hartford

14221

Investigative Site, Williamsville

15213

Investigative Site, Pittsburgh

23294

Investigative Site, Richmond

27103

Investigative Site, Winston-Salem

27215

Investigative Site, Burlington

27262

Investigative Site, High Point

28144

Investigative Site, Salisbury

28205

Investigative Site, Concord

28209

Investigative Site, Charlotte

28601

Investigative Site, Hickory

30005

Investigative Site, Alpharetta

30060

Investigative Site, Marietta

30076

Investigative Site, Roswell

30078

Investigative Site, Snellville

30342

Investigative Site, Atlanta

32168

Investigative Site, New Smyrna Beach

32803

Investigative Site, Orlando

33021

Investigative Site, Hollywood

33331

Investigative Site, Weston

33409

Investigative Site, West Palm Beach

33607

Investigative Site, Tampa

34237

Investigative Site, Sarasota

34474

Investigative Site, Ocala

35242

Investigative Site, Birmingham

45212

Investigative Site, Cincinnati

46143

Investigative Site, Greenwood

47714

Investigative Site, Evansville

48507

Investigative Site, Flint

49085

Investigative Site, Saint Joseph

53226

Investigative Site, Milwaukee

60160

Investigative Site, Melrose Park

61615

Investigative Site, Peoria

62269

Investigative Site, O'Fallon

63017

Investigative Site, Chesterfield

63136

Investigative Site, St Louis

64114

Investigative Site, Kansas City

66606

Investigative Site, Topeka

68114

Investigative Site, Omaha

68510

Investigative Site, Lincoln

73008

Investigative Site, Bethany

73034

Investigative Site, Edmond

75110

Investigative Site, Corsicana

75231

Investigative Site, Dallas

76104

Investigative Site, Fort Worth

77005

Investigative Site, Houston

77566

Investigative Site, Lake Jackson

79106

Investigative Site, Amarillo

80012

Investigative Site, Aurora

80033

Investigative Site, Wheat Ridge

80122

Investigative Site, Littleton

84010

Investigative Site, Bountiful

84070

Investigative Site, Sandy City

84124

Investigative Site, Salt Lake City

85206

Investigative Site, Mesa

85224

Investigative Site, Chandler

85282

Investigative Site, Tempe

85635

Investigative Site, Sierra Vista

90048

Investigative Site, Los Angeles

90505

Investigative Site, Torrance

91786

Investigative Site, Upland

92108

Investigative Site, San Diego

92591

Investigative Site, Temecula

92660

Investigative Site, Newport Beach

94027

Investigative Site, Atherton

97205

Investigative Site, Portland

97477

Investigative Site, Springfield

98101

Investigative Site, Seattle

98208

Investigative Site, Everett

98233

Investigative Site, Mountlake Terrace

98499

Investigative Site, Lakewood

98664

Investigative Site, Vancouver

01757

Investigative Site, Milford

02472

Investigative Site, Watertown

08648

Investigative Site, Lawrenceville

07052

Investigative Site, West Orange

Sponsors

Lead Sponsor

All Listed Sponsors
collaborator

Procter and Gamble

INDUSTRY

lead

Novartis

INDUSTRY